In the News
GNS CEO Colin Hill joins rank of Top 50 Healthcare Technology CEOs of 2019
The Healthcare Technology Report evaluates the hundreds of CEOs that lead exemplary organizations in the fields of medical devices, biotech, healthcare analytics, healthcare software and other related areas. They gather data on each nominee’s professional background...
read more
Adding Artificial Intelligence to Drug Discovery – Iya Khalil interviewed by GEN News
"AI is being used to really leverage learning from large-scale datasets, and those large-scale datasets are used to get to better novel targets." - Iya Khalil, GNS Co-Founder and COO, joins Mike May of Genetic Engineering & Biotechnology News to discuss AI in drug...
read more
GNS Co-founder, Iya Khalil interviewed by BioCentury: A Frequentist and a Bayesian Walk Into a Trial
GNS Co-Founder and COO Iya Khalil weighed in on the stand-off between Bayesians and frequentist. Read the full piece here.
read moreEvents
Colin Hill speaks on AI and Machine Learning in Cancer Medicine at Milken Institute 2019 Global Conference
The panel will focus on uses of ‘artificial intelligence and machine learning’ for cancer early detection, diagnosis, drug development and clinical decision making. These technologies have the potential to accelerate our understanding of cancer at the cellular and the...
read more
Iya Khalil joins Plenary Keynote Panel on AI in Bio-IT at Bio-IT World Conference
Iya Khalil, GNS Healthcare's Chief Operating Officer and Co-founder, will be featured on the panel "AI in Practice: How New Technologies are Changing Bio-IT" at the Bio-IT World Conference on Wednesday April 17th at 8:00am. The conference is highlighting the...
read more
Colin Hill Moderates Panel on AI at Forbes Healthcare Summit
Colin Hill, GNS CEO and co-founder moderated panel at The Forbes Healthcare Summit, held November 29th. The panel, “How Smart Is Artificial Intelligence?” brought together industry leaders to discuss the potential of AI to change healthcare. Panelists included...
read morePress Releases
GNS Healthcare Presents Results of Metastatic Colorectal Cancer Collaboration with the Alliance for Clinical Trials in Oncology at ESMO 2018
Study identifies clinical and molecular drivers of survival at baseline to allow better risk stratification at initiation of treatment CAMBRIDGE, Mass.– [October 22, 2018] – GNS Healthcare (GNS), a leading precision medicine company, presented results in metastatic...
read moreGNS Healthcare Co-Founder and Chief Commercial Officer Iya Khalil Named to INC Magazine’s List of Top Female Founders for 2018
CAMBRIDGE, Mass.– October 5, 2018 – Each October, INC Magazine chooses leading women pioneers, entrepreneurs and innovators to profile in its annual Women Entrepreneurs issue. In their 2018 issue, GNS Co-Founder and Chief Commercial Officer Iya Khalil, PhD was...
read moreGNS Healthcare Names Healthcare Analytics Executive David Gascoigne as Chief Operating Officer
CAMBRIDGE, Mass.– October 3, 2018 – GNS Healthcare (GNS), a leading precision medicine company, has tapped data analytics veteran David Gascoigne as its Chief Operating Officer. Gascoigne has two decades of experience scaling and leading data analytics businesses in...
read more